Print

INITIATION OF ENROLLMENT IN PIVOTAL PHASE III CLINICAL STUDY OF ORAL LAQUINIMOD FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS

2007-11-07



pdfINITIATION OF ENROLLMENT IN PIVOTAL PHASE III CLINICAL STUDY



Back